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ABSTRACT Empirical evidence from clinical, nonhuman animal, and in vitro studies point to links between
immune function and gonadal steroids, including potential androgenic immunosuppression and estrogenic immunoen-
hancement. This study was designed to test links between steroids and one marker of mucosal humoral immunity—
immunoglobulin A (IgA) in healthy individuals, to facilitate comparisons with other species and clinical populations, as
there are few existing studies with healthy humans that also allow gender/sex investigations. Participants (86 women,
91 men) provided a saliva sample for measurement of testosterone (T), estradiol (E2), and IgA. Results showed that E2
was significantly and positively correlated with IgA in women, and group analyses by E2 quartile showed that this asso-
ciation was linear. No significant correlations or nonlinear associations were seen between T and IgA in men or women,
or E2 and IgA in men. Evidence from this study indicates that IgA and E2 are significantly associated in healthy pre-
menopausal women. Am. J. Hum. Biol. 22:348–352, 2010. ' 2009 Wiley-Liss, Inc.
Behavioral ecologists have considered why androgens
like testosterone (T) are not subject to runaway selection
and instead appear to be moderated (e.g. Ketterson et al.,
2005; Reed et al., 2006). One possibility is that higher T
entails costs like immunosuppression. Accordingly, andro-
genic immunosuppression is one foundation for the immu-
nocompetence handicap hypothesis (ICHH: Folstad and
Karter, 1992; cf. Hamilton and Zuk, 1982), which posits
that T is an immunosuppressive mechanism driving ener-
getic trade-offs between male secondary sexual character-
istics and health.
Interactions between the endocrine and immune sys-
tems have been understood to exist for some time (e.g.
Grossman, 1985) and evidence indicates males and
females show different though overlapping patterns of im-
munity and mortality (e.g. Butterworth et al., 1967).
Males of many species tend to develop more infections,
and also exhibit fewer autoimmune diseases, than females
(Klein, 2000b), in part related to sex-specific levels of T
and estradiol (E2) (Klein, 2000a,b; cf. Bilbo and Nelson,
2001). Findings link T and lower immunity in both experi-
mental studies of T administration and correlational stud-
ies in males (e.g. Peters, 2000; Duffy and Ball, 2002; Yao
et al., 2003; Owen-Ashley et al., 2004; Deviche and Cortez,
2005; Muehlenbein et al., 2006; for a review, see Muehlen-
bein and Bribiescas, 2005) and females (e.g. Zysling et al.,
2006), though evidence is mixed (e.g. Kurtz and Sauer,
1999; Verhulst et al., 1999; Zala et al., 2008; for a review,
see Roberts et al., 2004). These associations can be bidirec-
tional, and evidence suggests that immune challenges can
suppress T in some mammals (Boonekamp et al., 2008).
In healthy humans, correlational studies have provided
weak or conflicting evidence. In one study with healthy
men, T was weakly or not at all (depending on statistical
method) linked to one measure of immunity and/or
immune responses to illness (C-reactive protein), and not
linked at all to another (white blood cell count) (Lassek
and Gaulin, 2009). Two other studies provide conflicting
evidence that healthy men with higher T report either
more (Booth et al., 1999) or no difference in number of
(Granger et al., 2000) colds. Granger et al. also looked at
correlations between T and various measures of immunity
in humans, generally finding no associations (B lympho-
cytes, monocytes, IgA, and IgG), or extremely small posi-
tive correlations (in the unexpected direction: T lympho-
cytes, CD4 cells, CD8 cells, IgM). In contrast to T being
linked with immunosuppression (but not exclusively), E2
is linked with immunoenhancement from correlational
and experimental studies (e.g. Ashcroft et al., 1997;
Angele and Faist, 2000; Klein, 2000b; Johansson et al.,
2001). Evidence also comes from healthy women, by the
use of correlational studies over women’s menstrual cycles
(e.g. with IgG, IgA, interleukin 10 and 1b: Kutteh et al.,
1998) and studies of synthetic E2 administration via hor-
monal contraceptives. However, most research on immu-
nity and T is conducted with males, and most research on
immunity and E2 is conducted with females. And, there
has been little in vivo research into population level asso-
ciations between immunity and T in healthy humans or
other primates (Muehlenbein and Bribiescas, 2005).
Muehlenbein and Bribiescas (2005) note that understand-
ing associations between steroids and immunity requires
examinations even in healthy individuals, as well as indi-
viduals with illnesses.
Despite the mixed evidence on links between T and im-
munity from human and nonhuman species, some studies
draw upon androgenic immunosuppression and the ICHH
to explain the value of masculine traits in humans with-
out assaying immunity or androgens directly (e.g. Penton-
Voak and Perrett, 2000; Little et al., 2001; Li and Kenrick,
2006; Gangestad et al., 2007; Bressan and Stranieri, 2008;
cf. Adamo and Spiteri, 2009), though supportive evidence
is ambiguous and sparse (e.g. Swaddle and Reierson,
2002; Rhodes et al., 2003; Boothroyd et al., 2005; Apicella
et al., 2007; Apicella and Feinberg, 2009). Understanding
how T and immunity are associated in healthy men will
help to test the assumptions that the aforementioned
studies are based on, i.e. that healthy men’s masculinity
can be a marker for health.
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Research on population-level associations between any
markers of immunity and T or E2 are limited in healthy
humans, and generally conducted within only one gender/
sex. Accordingly in this article, I test for correlations
between salivary immunoglobulin A (IgA) and steroids (T
and E2) in women and men. IgA is one measure of mucosal
immunity, and one of many possible measures of immu-
nity; it is the most abundant immunological constituent of
saliva and is involved in early-stage mucosal defense
(Brandtzaeg, 2007). For example, higher levels of IgA are
associated with lower incidence of subsequent infection/
illness (e.g. Gleeson et al., 1999; Neville et al., 2008). And,
IgA is the primary defense at the initial stage of exposure
to pathogens and is thus relevant to considerations of
immune function in healthy individuals (Mestecky and
McGhee, 1987). There are serious limitations to using
only one measure of immunity, and similarly there are
limitations to only using IgA given that there are a host of
Ig’s and Ig’s constitute only one aspect of the complex
immune system. Still, epidemiological and behavioral
studies have employed single immune measures like IgA
successfully to understand how other variables may be
related to this one aspect of the immune system (e.g.
Libicz et al., 2006; Gallagher et al., 2008; Hasselrot et al.,
2009). Helpfully, IgA can be measured in saliva along with
gonadal steroids. I expected positive correlations between
E2 and IgA, and negative correlations between T and IgA;
given past mixed evidence and few studies in healthy
humans, this study was exploratory.
METHODS
Participants
Participants were recruited as part of a larger study
designed to address this question of steroid-immunity
associations as well as questions unrelated to immunity
and this article. Participants were 91 men and 86 women,
recruited from the community via advertisements and via
the Psychology Subject Pool, and received a small mone-
tary compensation or class credit respectively for partici-
pating. Data from participants who reported using hormo-
nal medications or menopause were excluded. Partici-
pants were mostly students. Throughout, I use gender/sex
despite the article’s focus on physiology, because associa-
tions cannot knowingly be attributed to biology or gender
socialization. Healthy participants were recruited, but
some participants volunteered despite use of medications
or presence of illness; these participants were excluded
from analyses.
Methods and procedure
This study was approved by the Institutional Review
Board at Indiana University Bloomington. Participants
were tested between 13:00 and 18:00 to control for diurnal
rhythms in hormones (Axelsson et al., 2005). Participants
completed a questionnaire about health and demo-
graphics, including current illness, infections, and medi-
cation usage (including past use of hormonal contracep-
tives). Participants also provided saliva samples (3–
4 ml) by spitting into 17 ml polystyrene tubes. To avoid
potential blood contamination from gum abrasion or gen-
eral contamination from exogenous substances, we asked
participants to refrain from eating, smoking, brushing
their teeth, or drinking (though water was allowed) for 1 h
prior to the session. Tubes were frozen until assay, which
were conducted at the Core Biomarkers Lab at Yerkes Pri-
mate Research Center at Emory University via radioim-
munoassay (salivary T, E2) and ELISA (salivary IgA).
Assays were from commercially prepared kits from Sali-
metrics, LLC, (E, IgA) (State College, PA) and Diagnostic
Systems Laboratories (T) (Webster, TX). For E, the assay
range was 1–32 pg/ml; the interassay coefficients of varia-
tion were 7.8% at 0.107 lg/dl, 5.48% at 1.071 lg/dl, and
10.21% at 0.20 lg/dl; the intra-assay coefficient of varia-
tion was 10.35% at 0.22 lg/dl. For salivary IgA, the assay
range was 2.50–600.00 lg/ml; the interassay coefficients
of variation were 14.85% at 28.30 pg/ml and 11.68% at
197.06 pg/ml; the intraassay coefficient of variation was
9.96% at 278.10 pg/ml. For T, the assay range was 2–500
pg/ml; the interassay coefficients of variation were 19.16%
at 5.03 pg/ml, 15.08% at 170.81 pg/ml, and 16.40% at
25.31 pg/ml; the intraassay coefficient of variation was
3.41% at 26.89 pg/ml. There were participants for whom
assay results were unavailable (T, n 5 20; E2, n 5 26; IgA,
n 5 16), generally because of low sample quantity for
assays of all three analytes.
Statistics
I conducted Pearson’s correlations to test for linear asso-
ciations between salivary T, E, and IgA in women and
men. I conducted independent t-tests to examine gender/
sex differences in the three analytes. To check for nonlin-
ear associations (i.e. very high and low T or E2 might be
differentially associated with IgA), I divided women and
men into gender-/sex-specific steroid quartiles (n per quar-
tile 5 14). In women, the quartile ranges for T (pg/ml)
were (a) low: 13.5525 and below, (b) moderate-low:
13.55251–19.995, (c) moderate-high: 19.9951–29.3825, (d)
high: 29.3825 and up; the quartile ranges for E2 (pg/ml)
were (a) low: 1.735 and below, (b) moderate-low: 1.7351–
2.965, (c) moderate-high: 2.9651–4.69, (d) high: 4.691 and
above. In men, the quartile ranges for T (pg/ml) were (a)
low: 57.515 and below, (b) moderate-low: 57.5151–88.21,
(c) moderate-high: 88.211–122.71, (d) high: 122.711 and
up; the quartile ranges for E2 (pg/ml) were (a) low: 2.07
and below, (b) moderate-low: 2.071–3.49, (c) moderate-
high: 3.491–5.23, (d) high: 5.231and above. I conducted
analyses of variance (ANOVAs), and, when significant,
Least Significant Differences post-hoc analyses. I con-
ducted analyses of covariance (ANCOVA) to control for
age and time of day. Outliers (over 3 SD from the mean as
well as visual) were excluded from analyses (van Anders
and Dunn, 2009; for details) to provide a less noisy pattern
though their inclusion did not change the pattern of
results.
RESULTS
Salivary IgA and steroids
Participants with health conditions or using medica-
tions potentially affecting their immune systems were
excluded from analyses with salivary IgA.
Correlations. In women, IgA was significantly correlated
with E2 (Fig. 1), r(37) 5 0.37, P 5 0.019, but not with T,
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r(39) 5 0.03, P 5 0.849. T and E2 in women were not sig-
nificantly correlated, r(46) 5 0.15, P 5 0.318. In men,
there were no significant correlations between IgA and E,
r(55) 5 0.02, P 5 0.880, IgA and T, r(57) 5 0.02, P 5
0.890, or between E2 and T, r(68) 5 20.05, P 5 0.713. Par-
tial correlations controlling for age or time of sampling
showed the same patterns. A linear regression in women
showed that E2 was significantly associated with IgA,
including age and time of sampling, b 5 0.40, t(35) 5 2.32,
P 5 0.026.
Quartiles. In women, there was a significant difference in
IgA by E2 quartiles, F(3,32) 5 2.95, P 5 0.048 (Fig. 2).
Women in the lowest E2 quartile had significantly lower
IgA than the women in the moderate-high E2 quartile,
P 5 0.030, and the high E2 quartile, P 5 0.016. There was
a trend for women in the moderate-low E2 quartile to have
lower IgA than women in the high E2 quartile, P 5 0.081.
In men, there were no significant differences in IgA by E2
quartiles, F(3,53) 5 1.43, P 5 0.244 (Fig. 2).
There were no significant differences in IgA by T quar-
tile for women, F(3,41) 5 0.14, P 5 0.933, or men, F(3,55)
5 0.61, P 5 0.613 (Fig. 3).
Gender/sex differences in salivary steroids and IgA. As
has previously been shown, men had significantly higher
concentrations of T than women, t(81) 5 12.36, P < 0.001.
There were no significant differences in concentrations of
IgA between women and men, t(119) 5 1.34, P 5 0.182.
Counter to general (but not necessarily empirical) expect-
ations, there were no significant differences between con-
centrations of E in women and men, t(104) 5 0.34, P 5
0.738.
DISCUSSION
In this study, I tested healthy humans for population-
level evidence of associations between gonadal steroids
and IgA. As such, this is one of the first studies to examine
links between IgA and both T and E2 in healthy men and
women. Findings indicated significant positive linear
associations between E2 and salivary IgA in women but
not men. There was no indication of linear or nonlinear
associations between T and salivary IgA in men or women,
or between E2 and IgA in men. This partially accords with
Granger et al. (2000) who found no significant correlation
between T and IgA in healthy men.
IgA is involved in early-stage mucosal defense in
response to pathogens (Brandtzaeg, 2007; Mestecky and
McGhee, 1987) and lower IgA levels in healthy individuals
are predictive of later illness/infection (e.g. Gleeson et al.,
1999; Neville et al., 2008). As such, IgA is a relevant
marker to explore in steroid-immune associations in
healthy individuals. However, IgA is only one Ig, and Ig’s
are only one aspect of immunity; as such, other measures
of immunity may show evidence of androgenic immuno-
suppression. In addition, multiple samplings of any ana-
lyte will provide a more accurate estimate of individual
trait levels, though evidence shows high test-retest reli-
ability for T (Dabbs and de La Rue, 1991). An additional
consideration is that IgA, T, and E2 vary over the menstrual
Fig. 1. Scatterplot of correlations between estradiol and immuno-
globulin A (IgA) in women.
Fig. 2. Means and standard errors of immunoglobulin A (IgA) by
low, moderate-low, moderate-high, and high estradiol (E2) quartiles in
men and women. ‘‘*’’ indicates a significant difference at P < 0.05, ‘‘<’’
indicates a trend at P < 0.10.
Fig. 3. Means and standard errors of immunoglobulin A (IgA) by
low, moderate-low, moderate-high, and high testosterone (T) quartiles
in women and men.
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cycle; given that I did not control for cycle phase in this
study, steroid-IgA associations in women may be related
to variations in analytes over menstrual cycles.
Although the data from this study do not support
assumptions of population-level associations between T
and IgA in women or men, there is little extant research
on the question in healthy humans and future research is
needed to clarify this. Possibilities include studies follow-
ing endogenous fluctuations of gonadal steroids and im-
munity, or testing individuals pre-, peri-, and post-illness.
Additional and/or broader measures of immunity may
show a different pattern. Still, data from this study sug-
gest that the assumptions upon which the theoretical
value of masculine traits are built, i.e. population-level
negative correlations between T and initial stages of im-
munity in healthy men (e.g. Penton-Voak and Perrett,
2000; Li and Kenrick, 2006; Gangestad et al., 2007), need
to be further tested (Adamo and Spiteri, 2009; Boothroyd
et al., 2005; Roberts et al., 2004).
In contrast to what is reported in some species but con-
sistent with evidence in healthy members of other species
(e.g. Klein, 2000a) including humans (Butterworth et al.,
1967), there were no gender/sex differences in IgA.
Although men showed no associations between steroids
and IgA, women showed a significant and positive correla-
tion between E2 and IgA. This corresponds with previous
research linking higher estrogens and upregulated
immune function (e.g. Angele and Faist, 2000) (which can
be beneficial or detrimental, depending on other endoge-
nous circumstances). Evidence from this study points to a
linear association, as IgA levels were higher in increasing
E2 quartiles. As such, these data provides some of the first
evidence showing a correlation between higher E2 and IgA
at the population level in healthy women.
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